Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)
Genmab
Genmab
Bayer
Immatics US, Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
ModernaTX, Inc.
Prescient Therapeutics, Ltd.
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
OncoNano Medicine, Inc.
Fondazione Italiana Linfomi - ETS